Jason Alger Health Catalyst, Inc. (HCAT) insider trading activity

Jason Alger is Chief Financial Officer of Health Catalyst, Inc.. Currently has a direct ownership of 118,170 shares of HCAT, which is worth approximately $913,454. The most recent transaction as insider was on Jun 12, 2024, when has been sold 2,823 shares (Common Stock) at a price of $6.83 per share, resulting in proceeds of $19,281. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 118K

126.24% 3M change

96.73% 12M change

Total Value Held $913,454

Jason Alger Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 12 2024	SELL Open market or private sale	$19,281 $6.83 p/Share	2,823 Reduced 2.33%	118,170 Common Stock
Jun 03 2024	SELL Payment of exercise price or tax liability	$8,084 $6.53 p/Share	1,238 Reduced 1.01%	120,993 Common Stock
Mar 01 2024	SELL Payment of exercise price or tax liability	$19,915 $8.05 p/Share	2,474 Reduced 4.52%	52,231 Common Stock
Mar 01 2024	BUY Grant, award, or other acquisition	-	70,000 Added 36.41%	122,231 Common Stock
Feb 20 2024	BUY Grant, award, or other acquisition	-	2,778 Added 4.83%	54,705 Common Stock
Dec 06 2023	SELL Open market or private sale	$16,436 $7.55 p/Share	2,177 Reduced 4.02%	51,927 Common Stock
Dec 01 2023	SELL Payment of exercise price or tax liability	$21,143 $7.45 p/Share	2,838 Reduced 4.98%	54,104 Common Stock

Sep 06 2023	SELL Open market or private sale	$25,595 $11.65 p/Share	2,197 Reduced 3.71%	56,942 Common Stock
Sep 01 2023	SELL Payment of exercise price or tax liability	$10,943 $11.78 p/Share	929 Reduced 1.55%	59,139 Common Stock
Jun 06 2023	SELL Open market or private sale	$28,060 $11.84 p/Share	2,370 Reduced 3.8%	60,068 Common Stock
Jun 01 2023	SELL Payment of exercise price or tax liability	$11,981 $11.24 p/Share	1,066 Reduced 1.68%	62,438 Common Stock
Mar 03 2023	SELL Open market or private sale	$42,220 $14.23 p/Share	2,967 Reduced 5.09%	55,323 Common Stock
Mar 01 2023	SELL Payment of exercise price or tax liability	$23,064 $14.29 p/Share	1,614 Reduced 2.75%	57,148 Common Stock
Mar 01 2023	BUY Grant, award, or other acquisition	-	1,142 Added 1.92%	58,290 Common Stock
Feb 22 2023	BUY Grant, award, or other acquisition	-	25,000 Added 29.85%	58,762 Common Stock
Dec 06 2022	SELL Open market or private sale	$2,691 $10.39 p/Share	259 Reduced 0.76%	33,762 Common Stock
Dec 01 2022	SELL Payment of exercise price or tax liability	$26,635 $10.65 p/Share	2,501 Reduced 6.85%	34,021 Common Stock
Sep 06 2022	SELL Open market or private sale	$2,955 $11.28 p/Share	262 Reduced 0.71%	36,522 Common Stock
Sep 01 2022	SELL Payment of exercise price or tax liability	$6,583 $11.61 p/Share	567 Reduced 1.52%	36,784 Common Stock
Jun 06 2022	SELL Open market or private sale	$3,902 $14.95 p/Share	261 Reduced 0.69%	37,351 Common Stock
Jun 01 2022	SELL Payment of exercise price or tax liability	$8,278 $14.6 p/Share	567 Reduced 1.49%	37,612 Common Stock
Mar 07 2022	SELL Open market or private sale	$11,590 $25.14 p/Share	461 Reduced 1.19%	38,179 Common Stock
Mar 02 2022	SELL Payment of exercise price or tax liability	$4,190 $26.69 p/Share	157 Reduced 0.4%	38,640 Common Stock
Mar 01 2022	SELL Payment of exercise price or tax liability	$25,618 $26.63 p/Share	962 Reduced 2.52%	37,246 Common Stock
Mar 01 2022	BUY Grant, award, or other acquisition	-	1,551 Added 3.84%	38,797 Common Stock

Jason Alger

Chief Financial Officer

South Jordan, UT

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells HCAT shares.

Notify only if

Value

Insider Trading

Get notified when an Health Catalyst, Inc. insider buys or sells HCAT shares.

Notify only if

Operation

Value

Type

News

Receive news related to Health Catalyst, Inc.

Track Activities on HCAT

Account